ATC Group: V08CA09 Gadobutrol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08CA09 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08C Magnetic resonance imaging contrast media
4 V08CA Paramagnetic contrast media
5 V08CA09 Gadobutrol

Active ingredients in V08CA09

Active Ingredient

Gadobutrol is a gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI).

Related product monographs

Document Type Information Source  
 GADOVIST Solution for injection in prefilled syringe/cartridge MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Malta (MT)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.